arrow
G

Gerard Espinosa

University of Barcelona
H指数:72
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anifrolumab-Behandlung bei kutanem Lupus erythematodes mit und ohne systemische Beteiligung: Eine retrospektive Studie

安尼福利单抗治疗有无系统性累及的皮肤红斑狼疮:一项回顾性研究

2026-06-040
PRE
Changing Patterns in Hospitalisations of Patients with Systemic Lupus Erythematosus over Three Decades at a Tertiary Referral Centre in Catalonia

过去三十年间加泰罗尼亚一家三级转诊中心系统性红斑狼疮患者住院模式的转变

2026-04-300
OA
Peripheral ulcerative keratitis (PUK) in autoimmune diseases: a severe ocular manifestation not always associated with systemic disease activity

自身免疫性疾病中的周边溃疡性角膜炎(PUK):一种严重的眼部表现,并非总是与系统性疾病活动相关

2026-02-230
PRE
Anifrolumab Treatment in Cutaneous Lupus Erythematosus with and without systemic involvement: A Retrospective Study

安巴利珠单抗治疗有无系统性累及的皮肤狼疮:一项回顾性研究

2026-02-150
PRE
Catastrophic antiphospholipid syndrome: Clinical characteristics and outcomes in a non-caucasian population - A five-year experience from a single centre

灾难性抗磷脂综合征:非高加索人群的临床特征与结局——一项单中心五年经验研究

Lupus
IF1.9
2026-01-010
PRE
The impact of demographics on organ damage in Behçet's syndrome: a cross-sectional analysis of the international PROBE cohort

人口统计学对贝赫切特综合征中器官损伤的影响:国际PROBE队列的横断面分析

2025-12-011
OAAI
Real-world effectiveness and safety of voclosporin in the treatment of lupus nephritis with poor prognostic clinical and histological factors

真实世界中voclosporin治疗具有不良临床和病理学因素的狼疮肾炎的有效性与安全性

2025-10-010
OAAI
Prediction model for renal outcomes in Latin American mestizo population with proliferative lupus nephritis: a multicenter retrospective analysis

拉丁美洲混血人群中增生性狼疮肾炎肾结局的预测模型:一项多中心回顾性分析

2025-10-010
OAAI
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

ERN ReCONNET–SLICC–SLEuro专家共识:罕见系统性红斑狼疮表现的药物治疗管理

2025-05-230
PRE
Influence of gender on Behcet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behcet's Disease Registry
2025-03-010
OAAI
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome
2024-08-111
OAAI